Product Overview
Product: KLOW Peptide (80 mg blend), derived from Klotho protein for high-throughput research.
Lyophilized powder, USA-made purity ≥98%. For **research purposes only**, not for human or veterinary use :contentReference[oaicite:1]{index=1}.
Batch-tested purity ≥98%. COA available upon request — email providers@theratideusa.com.
- Tissue regeneration & wound healing: KLOW blend is formulated for studies on tissue repair, inflammation modulation, and metabolic regulation :contentReference[oaicite:2]{index=2}.
- Renal protection (Klotho mechanisms): A Klotho-derived peptide (e.g., KP6) has demonstrated kidney-fibrosis prevention via TGF‑β signaling inhibition :contentReference[oaicite:3]{index=3}.
- Metabolic regulation: Klotho peptides are being studied for their role in metabolic homeostasis, including insulin sensitivity and anti-inflammatory pathways :contentReference[oaicite:4]{index=4}.
Data based on non-human cell & animal models; human efficacy remains under investigation.
What is KLOW?
A peptide blend based on Klotho sequences, aimed at supporting research in tissue health, inflammation, and metabolism.
Intended use?
Designed for in vitro or in vivo research studies; not for direct ingestion or clinical use.
How is it administered?
Typically reconstituted with sterile water and administered via injection in controlled research settings.
Safety considerations?
Handle in lab environments with proper PPE. No human safety data published; follow standard research protocols.
For research use only — **NOT** for human or veterinary use, or as a dietary supplement.
Safety: Use per lab-grade standards with appropriate PPE and storage at ≤ –20 °C.
FDA Notice: Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent disease.
